Beetroot Extract Supplementation Associated With an Exercise Protocol for Chronic Kidney Disease Patients
Recruiting · NCT06286748 · Interventional (participants receive a specific treatment) · Lead sponsor: Universidade Federal Fluminense
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Chronic kidney disease (CKD) patients often present systemic inflammation and oxidative stress, resulting in metabolic disorders and high rates of disease-associated cardiovascular death. The literature has indicated that dietary control, the use of bioactive compounds, and the practice of regular physical exercise are essential for the prevention and management of CKD and its complications. In this context, beetroot (Beta vulgaris rubra) deserves attention as it is a source of several bioactive compounds, such as nitrate, betaine, and betalain, with beneficial effects for CKD patients, including anti-inflammatory, antioxidant effects, reduction of blood pressure, and vasodilatory action. The antioxidant and anti-inflammatory properties, in addition to their vasodilatory and antihypertensive capacity, can make supplementation of beetroot an excellent nutritional strategy to help in the treatment of CKD patients. So, this research project will bring contributions to the scientific world, providing strategies for application in clinical practice and the care of patients with CKD, on the use of beetroot associated with an exercise protocol as a non-pharmacological strategy in modulating inflammation, oxidative stress, and improved functional capacity. Furthermore, when supplemented hours before physical training, has been identified as an important factor in improving performance in these activities. Therefore, this study aims to evaluate the effects of supplementation (acute and chronic) of beetroot extract associated with an exercise protocol on complications associated with CKD.
Who can take part
Inclusion criteria
- Patients with CKD undergoing conservative treatment (stages G3a-G4);
- Aged between 18 and 65 years old;
- Patients undergoing nutritional monitoring for more than 6 months.
Exclusion criteria
- Patients using catabolic drugs;
- Smokers
- Pregnant women;
- Using antibiotics and of proton pump inhibitors in the last 3 months;
- Antioxidant supplements and habitual intake of beetroot or nitrate supplement;
- Those who are clinically unstable (unstable angina, atrial fibrillation, significant cardiac arrhythmia and acute illness in the last month; and glycemic lability);
- Unable to exercise (amputation without prosthesis); musculoskeletal pain at rest or with minimal physical activity, inability to sit or walk without assistance, use of a walking device, dyspnea at rest or with light exertion;
- Those with autoimmune diseases and infectious diseases, cancer, liver disease and AIDS.
- Patients with parathormone (PTH) levels above 500pg/mL;
- Those who are allergic or intolerant to the components of the juice.
- Patients with any impediment to completing the proposed exercise protocol, such as due to travel or difficulty accessing the location where the research will be carried out.
Where it is running
1 location listed.
- Denise Mafra - Rio de Janeiro, Rio de Janeiro, Brazil